Login To Trade  |  About IIFL
  • NIFTY  8001.95  53 0.67%
  • SENSEX 26392.38  161.19 0.61%
  1. General
  2. Others

  3. Others

Dr. Reddy launches Sildenafil tablets

India Infoline News Service | Mumbai | November 19, 2012 09:51 IST

The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.

Dr. Reddy's Laboratories announced today that it has launched Sildenafil Tablets (20 mg), a bioequivalent generic version of REVATIO® (Sildenafil) Tablets in the US market on November16, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Sildenafil Tablets.


The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.


Dr. Reddy's Sildenafil Tablets in 20 mg are available in 90 count bottle sizes.

BSE 4,178.70 47.15 (1.14%)
NSE 4,180.75 50.65 (1.23%)

***Note: This is a NSE Chart


Get Top 500 Company Research from acclaimed IIFL Research Team...Click Here!!!

Read more on: Dr.  Reddy,Sildenafil  tablets 
article
113110705590
Dr. Reddy launches Sildenafil tablets
Dr. Reddy launches Sildenafil tablets
The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.
http://www.indiainfoline.com/article/news-top-story/dr-reddy-launches-sildenafil-tablets-113110705590_1.html
November 19, 2012 09:51 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Dr. Reddy,Sildenafil tablets
Others
$rawVideoFileUrl$
$videoPlayerUrl$
News
Recent Reports

Stability in US and Europe to aid export growth

India Infoline Research Team / 10:47, Aug 24, 2015

In spite of massive improvement in CV demand, standalone revenues for Banco Products Ltd registered muted performance with sales at Rs. 113cr in Q1 FY16.